1. Home
  2. AUROW vs BBIO Comparison

AUROW vs BBIO Comparison

Compare AUROW & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Innovation Inc. Warrant

AUROW

Aurora Innovation Inc. Warrant

N/A

Current Price

$0.06

Market Cap

0.0

Sector

Technology

ML Signal

N/A

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$74.78

Market Cap

15.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUROW
BBIO
Founded
2017
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
15.9B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
AUROW
BBIO
Price
$0.06
$74.78
Analyst Decision
Strong Buy
Analyst Count
0
25
Target Price
N/A
$86.33
AVG Volume (30 Days)
27.8K
1.9M
Earning Date
04-30-2025
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
4.35
N/A
EPS
N/A
N/A
Revenue
$3,000,000.00
$502,076,000.00
Revenue This Year
N/A
$89.45
Revenue Next Year
N/A
$73.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
126.26
52 Week Low
$0.05
$48.78
52 Week High
$0.87
$93.42

Technical Indicators

Market Signals
Indicator
AUROW
BBIO
Relative Strength Index (RSI) 32.66 32.21
Support Level N/A $70.65
Resistance Level $0.25 $79.13
Average True Range (ATR) 0.02 2.03
MACD -0.00 -0.74
Stochastic Oscillator 4.90 11.90

Price Performance

Historical Comparison
AUROW
BBIO

About AUROW Aurora Innovation Inc. Warrant

Aurora Innovation is a US autonomous driving provider for heavy trucks. The company produces and sells its Aurora Driver system, which includes hardware installed in a vehicle, software to autonomously drive it, and data management to maintain and improve the software. Aurora targets long-haul routes. The company currently offers its trucking-as-a-service model, where it owns and operates the trucks and makes deliveries for customers. The company plans to start selling its driver-as-a-service model next year, where fleet owners will own the trucks and Aurora's software will operate them.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: